Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 43.13m | 6.48% |
| Gross profit | 15.26m | 3.70% |
| Net profit | -9.76m | 196.10% |
| EBITDA | 4.38m | 77.27% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €522.59m |
Number of shares | 685.26m |
52-week high/low | €2.37 - €0.76 |
Dividends TTM | €0.0327 |
Beta | 0.28 |
P/E ratio | -10.81 |
PEG ratio | 0.12 |
P/B ratio | 0.41 |
P/S ratio | 2.83 |
Company profile
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey. The company's Health segment produces and sells human health and veterinary medicines. Its Real Estate Development segment develops real estate properties; and provides consulting services regarding land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.
| Name | EIS Eczacibasi Ilac ve Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS |
| CEO | Emin Fadillioglu |
| Headquarters | Istanbul,
ib Turkey |
| Website | |
| IPO | 10/05/2000 |
| Employees | 904 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Ist | ECILC.IS |